Corrigendum to "Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges" [Pharmacology & Therapeutics 212 (2020) 107539]
1 State Key Laboratory of Anti-Infective Drug Development, Sunshine Lake Pharma Co., Ltd., Dongguan 523871, China; Department of Pharmacology & Toxicology, Sunshine Lake Pharma Co., Ltd., Dongguan 523871, China.
2 State Key Laboratory of Anti-Infective Drug Development, Sunshine Lake Pharma Co., Ltd., Dongguan 523871, China.
3 State Key Laboratory of Anti-Infective Drug Development, Sunshine Lake Pharma Co., Ltd., Dongguan 523871, China; Department of Pharmacology & Toxicology, Sunshine Lake Pharma Co., Ltd., Dongguan 523871, China. Electronic address: lijing@hec.cn.
4 State Key Laboratory of Anti-Infective Drug Development, Sunshine Lake Pharma Co., Ltd., Dongguan 523871, China; Department of Pharmacology & Toxicology, Sunshine Lake Pharma Co., Ltd., Dongguan 523871, China. Electronic address: Baohua.gu@hec.cn.